Net profit of Morepen Laboratories rose 3.07% to Rs 27.51 crore in the quarter ended December 2025 as against Rs 26.69 crore during the previous quarter ended December 2024. Sales rose 6.93% to Rs 484.16 crore in the quarter ended December 2025 as against Rs 452.78 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales484.16452.78 7 OPM %9.577.98 - PBDT45.8040.14 14 PBT35.4235.21 1 NP27.5126.69 3 Powered by Capital Market - Live News

Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 10 February 2026.Powered by Capital Market - Live News

Net profit of Morepen Laboratories rose 17.27% to Rs 40.87 crore in the quarter ended September 2025 as against Rs 34.85 crore during the previous quarter ended September 2024. Sales declined 5.97% to Rs 411.58 crore in the quarter ended September 2025 as against Rs 437.73 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales411.58437.73 -6 OPM %7.4610.07 - PBDT31.1547.88 -35 PBT19.8646.02 -57 NP40.8734.85 17 Powered by Capital Market - Live News

Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News

Morepen Laboratories has received the rating IVR A-/ Stable for long term bank facilities availed by the company. Powered by Capital Market - Live News